You can check our recently released webinar “Use of ProtoPRED for in silico risk assessment under REACH and ICH M7«.
In this webinar, we discuss the applications of our computational tool ProtoPRED, with a special focus on the ProtoREACH and ProtoICH modules.
ProtoREACH is a computational tool specifically focused on REACH, a European Union regulation adopted to improve the protection of human health and the environment from the risks that can be posed by chemicals.
ProtoICH is a computational tool designed to predict the mutagenicity of compounds, accomplishing strict adherence to the ICH-M7 guideline, the official international regulation adopted to limit the potential carcinogenic risk of impurities in pharmaceuticals.
ProtoPRED allows you to predict the mutagenicity (ProtoICH) and a full suite of physico-chemical, toxicological, and ecotoxicological properties (ProtoREACH) of organic molecules (e.g. drugs, cosmetics ingredients, etc.).
The ProtoPRED platform shows a very interesting array of advantages:
ProtoQSAR is a company specializing since 2012 in the design and optimization of compounds through QSAR modelling and AI-powered molecular modelling.
Our experience is upheld by more than 80 scientific publications as well as participation in more than 25 national, European, and international projects. Our technology can be used in many areas, including drug discovery and development, veterinary, cosmetic, agrochemical, functional food, and more.
Further information about ProtoREACH, ProtoICH y otros productos y servicios de ProtoQSAR en estos enlaces.
You can better familiarize yourself with the company through our LinkedIn profile.
We remain at your disposal to resolve any doubts or provide any further information you may need on the contact page.
